| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6036976 | ABBVIE ENDOCRINE | Sustained release microspheres and preparation thereof |
Dec, 2016
(7 years ago) | |
Lupaneta Pack is owned by Abbvie Endocrine.
Lupaneta Pack contains Leuprolide Acetate; Norethindrone Acetate.
Lupaneta Pack has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Lupaneta Pack are:
- US6036976
Lupaneta Pack was authorised for market use on 14 December, 2012.
Lupaneta Pack is available in injectable, tablet;intramuscular, oral dosage forms.
The generics of Lupaneta Pack are possible to be released after 13 December, 2016.
Drugs and Companies using LEUPROLIDE ACETATE; NORETHINDRONE ACETATE ingredient
Market Authorisation Date: 14 December, 2012
Treatment: NA
Dosage: INJECTABLE, TABLET;INTRAMUSCULAR, ORAL
More Information on Dosage
LUPANETA PACK family patents
